Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

Saved in:

Bibliographic Details
Main Authors:	Cordelia Dunai, Smita S. Iyer, William J. Murphy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	immunology virology SARS-CoV-2 mouse models preclinical models
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1548624/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes
by: Olivia A. Smith, et al.
Published: (2024-12-01)

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
by: Olubukola M. Abiona, et al.
Published: (2025-02-01)

Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses
by: Mansaku Hirai, et al.
Published: (2025-02-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals
by: Najwa D. Aljehani, et al.
Published: (2025-01-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)

Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development
by: Huixiong Deng, et al.
Published: (2025-01-01)

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
by: Fabrizio Angius, et al.
Published: (2024-12-01)

Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response
by: Hend Jarras, et al.
Published: (2025-01-01)

Vaccination Against SARS-Cov-2 among Patients with Parkinson’s Disease Based on the Results of COVPARK-LT Study
by: R. Kaladytė Lokominienė, et al.
Published: (2024-02-01)

Long-term effects of SARS-CoV-2 infection and vaccination in a population-based pediatric cohort
by: Jakob Höppner, et al.
Published: (2025-01-01)

A SARS‐CoV‐2 EG.5 mRNA vaccine induces a broad‐spectrum immune response in mice
by: Hongyu Wang, et al.
Published: (2025-01-01)

Changes in cortisol secretion and the role of the glucocorticoid receptor in the development of the immune response in patients with SARS-CoV-2 infection
by: Malvina Todorova, et al.
Published: (2025-02-01)

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01)

Neurological side effects of SARS-CoV-2 vaccination are common and can be severe
by: Josef Finsterer
Published: (2025-02-01)

Placental Infection with Different SARS-CoV-2 Variants Leading to Stillbirth: Report of Two Cases
by: Miriam A. Snow, et al.
Published: (2025-01-01)

Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate
by: Marcin Bazylewicz, et al.
Published: (2025-01-01)

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
by: Linda Mastromanno, et al.
Published: (2025-01-01)

Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation
by: Aminata Mbaye, et al.
Published: (2025-01-01)

TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders
by: Nincy Debeuf, et al.
Published: (2024-12-01)

The effect of SARS-CoV-2 Omicron BA. 5.2 infection on perioperative physiological indicators in orthopedic patients
by: Hao Wu, et al.
Published: (2025-01-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand
by: Daniel Ward, et al.
Published: (2025-01-01)

Stochastic Modelling of the Dynamics of the SARS-CoV-2 Epidemic: An Africa Perspective
by: Rasaki, Olawale Olanrewaju, et al.
Published: (2021)

Histoplasmosis e infección por SARS-CoV-2 en un paciente críticamente enfermo
by: Isasio Serna, et al.
Published: (2023-01-01)

Coatomer complex I is required for the transport of SARS-CoV-2 progeny virions from the endoplasmic reticulum-Golgi intermediate compartment
by: Ai Hirabayashi, et al.
Published: (2025-01-01)

Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination
by: Chien-Yu Ker, et al.
Published: (2023-07-01)

Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
by: Rafael Bayarri-Olmos, et al.
Published: (2024-12-01)

Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients
by: Amanda Bermejo-Gómez, et al.
Published: (2025-01-01)

Predictors of hospitalization, death and incomplete/non-recovery from SARS-CoV-2 in an ambulatory global population
by: Sarah L. Pett
Published: (2025-02-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
by: Chin Shern Lau, et al.
Published: (2024-12-01)

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
by: Mie Suzuki Okutani, et al.
Published: (2025-02-01)

Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic
by: Temitope Isaac Adelusi, et al.
Published: (2025-01-01)

An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments
by: Ajit Ahlawat, et al.
Published: (2020-07-01)

Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
by: William P. Hanage, et al.
Published: (2024-12-01)

SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic
by: Roselyn F. Kaondera-Shava, et al.
Published: (2025-01-01)